Literature DB >> 2963503

Animal models for study of polycystic ovaries and ovarian atresia.

V B Mahesh1, T M Mills, C A Bagnell, B A Conway.   

Abstract

In the human, polycystic ovaries are generally accompanied by normal or elevated levels of serum LH, normal or slightly depressed FSH and by high levels of circulating estrogens and androgens. If the excess androgen secretion is reduced by one of several methods, ovulatory cycles are usually restored. Several animal model systems have been proposed for the study of the pathophysiology of the polycystic ovarian syndrome. These include neonatal androgenization, hCG administration to hypothyroid rats, injection of estradiol valerate and maintaining animals in constant light. In a model developed in this laboratory, pubertal or adult rats were treated with the weak androgen, dehydroepiandrosterone (DHA), to induce polycystic ovaries. This treatment also altered the blood levels of LH and FSH but the effect on gonadotropins and on the formation of the degenerative follicles was fully reversed following discontinuation of the androgen injections. The polycystic ovaries of the DHA-treated animals were steroidogenically more active than controls raising the possibility that the DHA was acting directly on the ovary in addition to an action on the pituitary-hypothalamus axis. In order to study the direct effect of androgens on the ovary, another animal model was developed in which immature, hypophysectomized rats were injected with pregnant mare serum gonadotropin (PMSG) to initiate follicular growth followed by a single injection of dihydrotestosterone (DHT). The androgen caused follicular atresia and decreased the number of ova shed in response to ovulation induction with hCG. The suppressive effects of DHT were entirely prevented by concomitant treatment with estradiol. The studies with DHT were continued using another batch of PMSG, but the DHT-induced increase in the rat of atresia and suppression of induced ovulation were no longer seen. However, when this same batch of PMSG was given with estrogen or with the antiandrogen flutamide, there was less atresia and the growth of follicles was actually enhanced. Based on these studies, it was postulated that the second batch of PMSG had greater LH activity than the first preparation and that the LH has stimulated endogenous androgen production. The ovarian follicles which appeared to be most susceptible to this DHT effect were small to medium in size and had a low capacity to synthesize estrogen. This possibility was confirmed in another animal model system in which immature rats were injected with PMSG and 4 separate injections of DHT and then sacrificed at several time points over the next 8 days.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2963503     DOI: 10.1007/978-1-4684-5395-9_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Remarkable features of ovarian morphology and reproductive hormones in insulin-resistant Zucker fatty (fa/fa) rats.

Authors:  Hiroyuki Honnma; Toshiaki Endo; Tamotsu Kiya; Ayumi Shimizu; Kunihiko Nagasawa; Tsuyoshi Baba; Takashi Fujimoto; Hirofumi Henmi; Yoshimitsu Kitajima; Kengo Manase; Shinichi Ishioka; Eiki Ito; Tsuyoshi Saito
Journal:  Reprod Biol Endocrinol       Date:  2010-06-24       Impact factor: 5.211

Review 2.  Significance of matrix metalloproteinases in the pathophysiology of the ovary and uterus.

Authors:  Toshiaki Endo; Tamotsu Kiya; Taeko Goto; Hirofumi Henmi; Kengo Manase; Hiroyuki Honnma; Tsuyoshi Baba; Shinichi Ishioka; Takuhiro Hayashi; Manabu Chida; Kazuyo Arima; Kiyohiro Yamazaki; Mika Kanaya; Atsushi Azumaguchi; Osamu Moriwaka; Hirofumi Kamiya; Tsuyoshi Saito
Journal:  Reprod Med Biol       Date:  2006-11-23

3.  Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroidism.

Authors:  Iptisam Ipek Muderris; Abdullah Boztosun; Gokalp Oner; Fahri Bayram
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

4.  Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats.

Authors:  Sarwat Jahan; Faryal Munir; Suhail Razak; Anam Mehboob; Qurat Ul Ain; Hizb Ullah; Tayyaba Afsar; Ghazala Shaheen; Ali Almajwal
Journal:  J Ovarian Res       Date:  2016-12-07       Impact factor: 4.234

5.  Cysteine-Cysteine Motif Chemokine Receptor 5 Expression in Letrozole-Induced Polycystic Ovary Syndrome Mice.

Authors:  Kok-Min Seow; Pin-Shiou Liu; Kuo-Hu Chen; Chien-Wei Chen; Luen-Kui Chen; Chi-Hong Ho; Jiann-Loung Hwang; Peng-Hui Wang; Chi-Chang Juan
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

6.  An imbalance between apoptosis and proliferation contributes to follicular persistence in polycystic ovaries in rats.

Authors:  Natalia R Salvetti; Carolina G Panzani; Eduardo J Gimeno; Leandro G Neme; Natalia S Alfaro; Hugo H Ortega
Journal:  Reprod Biol Endocrinol       Date:  2009-07-01       Impact factor: 5.211

7.  Modulation of Cx43 and Gap Junctional Intercellular Communication by Androstenedione in Rat Polycystic Ovary and Granulosa Cells in vitro.

Authors:  Rabih Talhouk; Charbel Tarraf; Laila Kobrossy; Abdallah Shaito; Samer Bazzi; Dana Bazzoun; Marwan El-Sabban
Journal:  J Reprod Infertil       Date:  2012-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.